Preeclampsia Subtypes and Surrogate Markers of CVD Risk

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02337049

Enrollment

120

Registered

2015-01-13

Start date

2014-09-30

Completion date

2016-04-30

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preeclampsia

Keywords

Preeclampsia. Cardiovascular Disease (CVD) Risk.

Brief summary

In order to assess surrogate markers of cardiovascular risk in subtypes of preeclampsia, we will conduct a 10-year follow-up study comparing 40 women with a history of early onset preeclampsia; 40 women with a history of late onset preeclampsia and 40 women with a history of normotensive pregnancies. Eligible participants delivered at the Department of Obstetrics at Randers Regional Hospital 1998-2008. Early-onset preeclampsia is defined as preeclampsia that develops before 34 weeks of gestation, whereas late-onset preeclampsia develops at or after 34 weeks of gestation.

Interventions

None listed

Study design

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Healthy volunteers

Inclusion criteria

* Women who delievered at the Department of Obstetrics at Randers Regional Hospital 1998-2008

Exclusion criteria

* Current pregnancy or breastfeeding

Design outcomes

Primary

Measure	Time frame
Echocardiographic Markers of Cardiac Strain	10 years postpartum

Secondary

Measure	Time frame
Markers of arteriosclerosis and atherosclerosis	10 years postpartum
Circulating biomarkers of cardiovascular disease.	10 years postpartum

Countries

Denmark

Outcome results